Strategic Alliance between RAN BioLinks and Dataiku to Accelerate AI-Driven Clinical Research
Sunday, August 18, 2024
Ontario, August 2024 - RAN BIOLINKS, a leading data-driven service provider for clinical research, today announced a strategic alliance with Dataiku, the Universal AI platform, to enhance data-driven initiatives and artificial intelligence/machine learning (AI/ML) capabilities in healthcare organizations.
This collaboration combines RAN BIOLINKS' expertise in clinical research with Dataiku's cutting-edge data science and AI platform to offer healthcare organizations a powerful solution for accelerating their data-driven clinical research efforts.
Key highlights include:
1. Integrated Platforms: Combining RAN BIOLINKS' clinical research services with Dataiku's AI platform to provide a comprehensive solution for healthcare organizations.
2. Enhanced Data Analysis: Leveraging Dataiku's advanced analytics capabilities to unlock deeper insights from clinical data.
3. Accelerated AI/ML Adoption: Empowering healthcare organizations to rapidly develop and deploy AI/ML models for improved clinical outcomes.
4. Streamlined Workflows: Optimizing clinical research processes through automated data preparation, analysis, and reporting.
5. Scalable Solutions: Offering flexible and scalable solutions to meet the diverse needs of healthcare organizations of all sizes.
Rad Aniba, CEO, RAN BIOLINKS
"Our partnership with Dataiku marks a significant milestone in our mission to advance data-driven clinical research. By combining our deep industry knowledge with Dataiku's powerful AI platform, we're poised to deliver unprecedented value to healthcare organizations and ultimately improve patient outcomes."
"It’s our mission to democratize AI across the entire enterprise surface, and our commitment to supporting RAN BIOLINKS technologies and core processes with our platform is an incredible testament to the transformative impact of data-driven initiatives, " said Brian Power, Vice President, Americas Partnerships at Dataiku. “This collaboration will enable healthcare organizations to harness the full potential of their data, driving innovation and accelerating the pace of medical discoveries."
The RAN BIOLINKS and Dataiku alliance is set to transform the landscape of clinical research, offering healthcare organizations the tools and expertise needed to thrive in an increasingly data-driven world.
For more information about this partnership and its offerings, please visit https://www.ranbiolinks.com or contact us here.
About RAN BIOLINKS
RAN BIOLINKS’s mission is to make scientific research more accessible, efficient, and relevant. We help scientists and researchers find new ways to improve their work by taking over all the time-consuming operational tasks, building capacity around modern research methods, and connecting them with our network of experts and resources. By ensuring that all scientific research can be accelerated, we can create a better world for everyone.
About Dataiku
Dataiku is the Universal AI Platform, uniting the technology, teams, and operations needed for companies to build intelligence into their daily operations, from modern analytics to Generative AI. Together, they design, develop and deploy new AI capabilities, at all scales and in all industries. Organizations that use Dataiku enable their people to be extraordinary, creating the AI that will power their company into the future.
Founded in 2013, Dataiku has proven its ability to continue to develop its founding vision for Everyday AI, and to execute on its growth.
Connect with Dataiku through their blog, Twitter/X, LinkedIn, and YouTube.
WE SERVE A COMMUNITY OF HIGH PERFORMANCE SCIENTISTS
Our Services Make A Difference, Hear It From Our Collaborators
"More than a Thousand households enrolled in record time and followed up throughout the study with home visits (in the midst of lockdowns) is what I would call LARGE SCALE!"
I know that most studies (even before the COVID, but especially during the pandemic) took years between starting and locking down data (and that is not taking into account the actual study duration). The operational infrastructure that you enabled for ConCorD19 was the first time that all of us PIs were part of a study that was implemented within weeks of design and data locked down within a few weeks of study end. This is unprecedented in my experience
- Prof. Tobias Kollmann
Professor of System Vaccinology
"The day to day logistics of every aspect of the trial were managed, including procurement of the necessary biospecimen collection kits and transportation supplies"
Our COVID-19 clinical trial required coordination of field teams, timed biospecimen collection and the processing, storage and transportation of clinical samples (across international borders). The management of data that accrued in the trial database in real time ensured that the protocol was adhered to and provided the principle investigators tools to follow participant registration and biospecimen collection. In every regard, the operational needs of the trial were facilitated by RAN BioLinks. The day to day logistics of every aspect of the trial were managed, including procurement of the necessary biospecimen collection kits and transportation supplies, securing regulatory approvals for biospecimen transfers and coordinating border and customs requirements to expedite transfers. I look forward to working with RAN BioLinks in the future.
- Prof. Eleanore Fish
Professor & Associate Chair
Dept. Immunology, University of Toronto
Get In Touch
Location :
10212 Yonge Street, 202, Richmond Hill, Ontario, Canada, L4C 3B6
Email :
info@ranbiolinks.com